Does fear of COPD flare-ups keep you close to home?
The ENDURA-1 clinical research study is currently seeking
volunteers to evaluate an investigational medication for adults with COPD.
Chronic Obstructive Pulmonary Disease (COPD) is a broad term
that comprises several ongoing lung conditions such as emphysema and chronic
bronchitis. Key signs and symptoms may include difficulty breathing, tiredness,
and a chronic cough (with or without mucus). Symptoms may get worse at times,
called “exacerbations.” These flare-ups may do further damage to the lungs, so
it’s important to effectively treat COPD.
Right now, a research study is enrolling adults with uncontrolled
moderate to severe COPD. Study doctors are assessing an investigational
medication — a type of biologic medicine given as shots just under the skin.
They want to see if it can lower the number of moderate/severe exacerbations
(symptom flare-ups) and improve symptoms and quality of life compared to
placebo when used as add-on therapy. Researchers also want to assess how safe
the investigational medication is in this population.
Length of time in the study will vary by participant but is expected
to last a minimum of 1 and up to 2 years during which there will be, on
average, about one visit per month.
You may qualify to participate in this study if you:
- Are age 40 to 80.
- Have moderate to severe COPD.
- Are a current OR former smoker.
- Have had at least one exacerbation (symptom flare-up) in the
past 12 months that meet certain requirements.